ClinicalTrials HQ

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease

Active, not recruiting · NCT04120493 · Registry updated 2025-10-21
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's DiseaseCognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorderActive, not recruitingPhase 1 / Phase 22025-10-21NCT04120493

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
UniQure Biopharma B.V.5

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CenExel Rocky Mountain Clinical ResearchEnglewoodUnited States9
Johns Hopkins UniversityBaltimoreUnited States150
Ohio State UniversityColumbusUnited States169
Rush University Medical CenterChicagoUnited States283
The University of TexasHoustonUnited States2
University of Alabama at BirminghamBirminghamUnited States2
University of Arizona (Surgical Site Only)TucsonUnited States1
University of California, San FranciscoSan FranciscoUnited States72
University of Michigan Department of NeurologyAnn ArborUnited States1
University of Washington Medical CenterSeattleUnited States104
Vanderbilt University Medical CenterNashvilleUnited States427
Virginia Commonwealth University VCU School of Medicine, Department of NeurologyRichmondUnited States1